Abstract
Follicle stimulating hormone (FSH) is a member of the glycoprotein hormone family that includes luteinizing hormone (LH), thyroid stimulating hormone, and chorionic gonadotropin. These heterodimeric hormones share a common α subunit and differ in their hormone-specific β subunit. The biological activity is conferred only by the heterodimers. FSH and LH are synthesized in the same cells of the pituitary, the gonadotrophs1,2. FSH receptors are localized to Sertoli cells of the testes and granulosa cells of the ovary1,2. Minimal data has been accumulated so far involving human mutations in the FSHβ, LHβ, or the gonadotropin receptor genes. There are no known mouse strains with mutations in the FSHβ gene. To generate animal models for human diseases involving the gonadotropin signal transduction pathway, we produced mice deficient in the FSHβ subunit and therefore in FSH using ES cell technology. FSH-deficient females are infertile due to a block in folliculogenesis prior to antral follicle formation. Although FSH was predicted to be necessary for spermatogenesis and Sertoli cell growth in males, FSH-deficient males are fertile despite having small testes. Our findings have important implications for male contraceptive development in humans.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pierce, J.G. & Parsons, T.F. Glycoprotein hormones: structure and function. Annu. Rev. Biochem. 50, 465–495 (1981).
Bousfield, G.R., Perry, W.M. & Ward, D.N. Gonadotropins: chemistry and biosynthesis. In The Physiology of Reproduction (eds Knobil, E. & Neill, J.D.) 1749–1792 (Raven Press, New York, 1994).
Camper, S.A. et al. Implementing transgenic and embryonic stem cell technology to study gene expression, cell–cell interactions and gene function. Biol. Reprod. 52, 246–257 (1995).
Nishimori, K. & Matzuk, M.M. Transgenic mice in the analysis of reproductive development and function. Rev. Reprod. 1, 203–212 (1996).
Kendall, S.K., Samuelson, L.C., Saunders, T.L., Wood, R.I. & Camper, S.A. Targeted disruption of the pituitary glycoprotein hormone alpha-subunit produces hypogonadal and hypothyroid mice. Genes Develop. 9, 2007–2019 (1995).
Matzuk, M.M., Kumar, T.R. & Bradley, A. Different phenotypes for mice deficient in either activins or activin receptor type II. Nature 374, 356–360 (1995).
Kluin, P.M., Kramer, M.F. & DeRooij, D.G. Proliferation of spermatogonia and Sertoli cells in maturing mice. Anat. Embryol. 169, 73–78 (1984).
Orth, J.M. The role of follicle-stimulating hormone in controlling Sertoli cell proliferation in testes of fetal rats. Endocrinology 115, 1248–1255 (1984).
Matthews, C.H. et al. Primary amenorrhea and infertility due to a mutation in the β-subunit of follicle-stimulating hormone. Nature Genet. 5, 83–86 (1993).
Aittomáki, K. et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82, 959–968 (1995).
Aittomã, K. et al. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J. Clin. Endocr. Metab. 81, 3722–3726 (1996).
Tapanainen, J.S., Aittomãki, K., Min, J., Vaskivmo, T. & Huhtaniemi, I. Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nature Genet. 15, 205–206 (1997).
Aldhous, P. A booster for contraceptive vaccines. Science 266, 1484–1486 (1994).
Matzuk, M.M., Finegold, M.J., Su, J-G.J., Hsueh, A.J.W. & Bradley, A. α-lnhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360, 313–319 (1992).
Kumar, T.R., Kelly, M., Mortrud, M., Low, M.J. & Matzuk, M.M. Cloning of the mouse gonadotropin β subunit genes. I. Structure of the follicle stimulating hormone β subunit gene. Gene 166, 333–334 (1995).
Dong, J. et al. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 381, 531–535 (1996).
Laboratory manual for the examination of human semen and semen-cervical mucus interaction. (Cambridge University Press, Cambridge, 1992).
Hogan, B., Beddington, R., Costantini, F. & Lucy, E. in Manipulating the Mouse Embryo.A Laboratory Manual 2nd ed. (Cold Spring Harbor Laboratory Press, New York, 1994).
Kumar, T.R., Fairchild-Huntress, V. & Low, M.J. Gonadotrope-specific expression of the human follicle-stimulating hormone β-subunit gene in pituitaries of transgenic mice. Molec. Endocrinol. 6, 81–90 (1992).
Harlow, E. & Lane, D., In Antibodies. A Laboratory Manual 2nd ed. (Cold Spring Harbor Laboratory Press, New York, 1988).
Kumar, T.R. & Low, M.J. Hormonal regulation of human follicle-stimulating hormone-β subunit gene expression: GnRH stimulation and GnRH-independent androgen inhibition. Neuroendocrinolog 61, 628–637 (1995).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kumar, T., Wang, Y., Lu, N. et al. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet 15, 201–204 (1997). https://doi.org/10.1038/ng0297-201
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0297-201
This article is cited by
-
Cellular atlases of ovarian microenvironment alterations by diet and genetically-induced obesity
Science China Life Sciences (2024)
-
The emerging role of lysine succinylation in ovarian aging
Reproductive Biology and Endocrinology (2023)
-
Polymorphisms in FSHR modulating susceptibility to polycystic ovary syndrome: an updated meta-analysis
Journal of Ovarian Research (2023)
-
FSH and ApoE4 contribute to Alzheimer’s disease-like pathogenesis via C/EBPβ/δ-secretase in female mice
Nature Communications (2023)
-
Clinical utility of serum 17-hydroxyprogesterone as a marker for medical therapy for male infertility: recommendations based on clinical scenarios
International Journal of Impotence Research (2023)